Return On Equity of CytomX Therapeutics, Inc. from 30 Jun 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
CytomX Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2016 to 30 Sep 2025.
  • CytomX Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 44%.
  • CytomX Therapeutics, Inc. annual Return On Equity for 2024 was -147%, a 17542% decline from 2023.
  • CytomX Therapeutics, Inc. annual Return On Equity for 2023 was 0.84%, a 99% decline from 2022.
  • CytomX Therapeutics, Inc. annual Return On Equity for 2022 was 159%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

CytomX Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 44% +86% 01 Jul 2025 30 Sep 2025
Q2 2025 159% +186% 01 Apr 2025 30 Jun 2025
Q1 2025 -553% -522% -1702% 01 Jan 2025 31 Mar 2025
Q4 2024 -147% -148% -17542% 01 Oct 2024 31 Dec 2024
Q3 2024 -41% -55% -413% 01 Jul 2024 30 Sep 2024
Q2 2024 -27% -77% -155% 01 Apr 2024 30 Jun 2024
Q1 2024 -31% -123% -133% 01 Jan 2024 31 Mar 2024
Q4 2023 0.84% -158% -99% 01 Oct 2023 31 Dec 2023
Q3 2023 13% -290% -96% 01 Jul 2023 30 Sep 2023
Q2 2023 50% -888% -95% 01 Apr 2023 30 Jun 2023
Q1 2023 92% +946% 01 Jan 2023 31 Mar 2023
Q4 2022 159% +433% 01 Oct 2022 31 Dec 2022
Q3 2022 303% +564% 01 Jul 2022 30 Sep 2022
Q2 2022 938% +1159% 01 Apr 2022 30 Jun 2022
Q1 2022 -854% -636% -293% 01 Jan 2022 31 Mar 2022
Q4 2021 -275% -121% -79% 01 Oct 2021 31 Dec 2021
Q3 2021 -260% -109% -72% 01 Jul 2021 30 Sep 2021
Q2 2021 -221% -94% -74% 01 Apr 2021 30 Jun 2021
Q1 2021 -217% -104% -93% 01 Jan 2021 31 Mar 2021
Q4 2020 -154% -30% -25% 01 Oct 2020 31 Dec 2020
Q3 2020 -151% -61% -68% 01 Jul 2020 30 Sep 2020
Q2 2020 -127% -51% -66% 01 Apr 2020 30 Jun 2020
Q1 2020 -113% -40% -55% 01 Jan 2020 31 Mar 2020
Q4 2019 -123% -35% -40% 01 Oct 2019 31 Dec 2019
Q3 2019 -90% -25% -38% 01 Jul 2019 30 Sep 2019
Q2 2019 -76% -1.5% -2% 01 Apr 2019 30 Jun 2019
Q1 2019 -73% +20% +21% 01 Jan 2019 31 Mar 2019
Q4 2018 -88% -17% -23% 01 Oct 2018 31 Dec 2018
Q3 2018 -65% +27% +30% 01 Jul 2018 30 Sep 2018
Q2 2018 -75% +9.8% +12% 01 Apr 2018 30 Jun 2018
Q1 2018 -93% -33% -55% 01 Jan 2018 31 Mar 2018
Q4 2017 -71% -9.7% -16% 01 Oct 2017 31 Dec 2017
Q3 2017 -92% -40% -76% 01 Jul 2017 30 Sep 2017
Q2 2017 -85% +7% +7.6% 01 Apr 2017 30 Jun 2017
Q1 2017 -60% 01 Jan 2017 31 Mar 2017
Q4 2016 -62% 01 Oct 2016 31 Dec 2016
Q3 2016 -52% 01 Jul 2016 30 Sep 2016
Q2 2016 -92% 01 Apr 2016 30 Jun 2016

CytomX Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -147% -148% -17542% 01 Jan 2024 31 Dec 2024
2023 0.84% -158% -99% 01 Jan 2023 31 Dec 2023
2022 159% +433% 01 Jan 2022 31 Dec 2022
2021 -275% -121% -79% 01 Jan 2021 31 Dec 2021
2020 -154% +6.7% +4.2% 01 Jan 2020 31 Dec 2020
2019 -160% -72% -82% 01 Jan 2019 31 Dec 2019
2018 -88% -17% -23% 01 Jan 2018 31 Dec 2018
2017 -71% -9.7% -16% 01 Jan 2017 31 Dec 2017
2016 -62% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.